102 related articles for article (PubMed ID: 1340121)
21. Mixed backbone antisense oligonucleotides: design, biochemical and biological properties of oligonucleotides containing 2'-5'-ribo- and 3'-5'-deoxyribonucleotide segments.
Kandimalla ER; Manning A; Zhao Q; Shaw DR; Byrn RA; Sasisekharan V; Agrawal S
Nucleic Acids Res; 1997 Jan; 25(2):370-8. PubMed ID: 9016567
[TBL] [Abstract][Full Text] [Related]
22. Phosphorothioate analogues of oligodeoxyribonucleotide: synthesis and activity as inhibitors of replication of human immunodeficiency virus.
Kim SG; Suzuki Y; Nakashima H; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1991 Sep; 179(3):1614-9. PubMed ID: 1930201
[TBL] [Abstract][Full Text] [Related]
23. Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity.
Tang JY; Temsamani J; Agrawal S
Nucleic Acids Res; 1993 Jun; 21(11):2729-35. PubMed ID: 8392706
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of HIV-1 in CEM cells by a potent TAR decoy.
Lee SW; Gallardo HF; Gaspar O; Smith C; Gilboa E
Gene Ther; 1995 Aug; 2(6):377-84. PubMed ID: 7584112
[TBL] [Abstract][Full Text] [Related]
25. Selective chemical autoligation on a double-stranded DNA template.
Herrlein MK; Letsinger RL
Nucleic Acids Res; 1994 Nov; 22(23):5076-8. PubMed ID: 7800502
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of site-specifically modified oligoribonucleotides for studies of the recognition of TAR RNA by HIV-1 tat protein and studies of hammerhead ribozymes.
Slim G; Pritchard C; Biala E; Asseline U; Gait MJ
Nucleic Acids Symp Ser; 1991; (24):55-8. PubMed ID: 1841380
[TBL] [Abstract][Full Text] [Related]
27. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
Sun LQ; Wang L; Gerlach WL; Symonds G
Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887
[TBL] [Abstract][Full Text] [Related]
28. Configurationally defined phosphorothioate-containing oligoribonucleotides in the study of the mechanism of cleavage of hammerhead ribozymes.
Slim G; Gait MJ
Nucleic Acids Res; 1991 Mar; 19(6):1183-8. PubMed ID: 1709484
[TBL] [Abstract][Full Text] [Related]
29. Rapid plasma clearance and metabolism in vivo of a phosphorothioate oligodeoxynucleotide with a single, internal phosphodiester bond.
Boado RJ; Kang YS; Wu D; Pardridge WM
Drug Metab Dispos; 1995 Nov; 23(11):1297-300. PubMed ID: 8591734
[No Abstract] [Full Text] [Related]
30. Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection.
Hoke GD; Draper K; Freier SM; Gonzalez C; Driver VB; Zounes MC; Ecker DJ
Nucleic Acids Res; 1991 Oct; 19(20):5743-8. PubMed ID: 1658742
[TBL] [Abstract][Full Text] [Related]
31. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion.
Wyatt JR; Vickers TA; Roberson JL; Buckheit RW; Klimkait T; DeBaets E; Davis PW; Rayner B; Imbach JL; Ecker DJ
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1356-60. PubMed ID: 7906414
[TBL] [Abstract][Full Text] [Related]
32. Physicochemical and biochemical properties of 2',5'-linked RNA and 2',5'-RNA:3',5'-RNA "hybrid" duplexes.
Wasner M; Arion D; Borkow G; Noronha A; Uddin AH; Parniak MA; Damha MJ
Biochemistry; 1998 May; 37(20):7478-86. PubMed ID: 9585561
[TBL] [Abstract][Full Text] [Related]
33. Comparative stability of eight different triple helices formed by differently modified DNA or RNA pyrimidine strands and a DNA hairpin.
Morvan F; Imbach JL; Rayner B
Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):327-34. PubMed ID: 9303184
[TBL] [Abstract][Full Text] [Related]
34. Complementary large loops determine the rate of RNA duplex formation in vitro in the case of an effective antisense RNA directed against the human immunodeficiency virus type 1.
Homann M; Rittner K; Sczakiel G
J Mol Biol; 1993 Sep; 233(1):7-15. PubMed ID: 8377194
[TBL] [Abstract][Full Text] [Related]
35. Phosphorothioate oligonucleotides block reverse transcription by the Rnase H activity associated with the HIV-1 polymerase.
Hatta T; Takai K; Yokoyama S; Nakashima H; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1995 Jun; 211(3):1041-6. PubMed ID: 7541196
[TBL] [Abstract][Full Text] [Related]
36. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
[TBL] [Abstract][Full Text] [Related]
37. Effect of structural variations in cholesteryl-conjugated oligonucleotides on inhibitory activity toward HIV-1.
Farooqui F; Sarin PS; Sun D; Letsinger RL
Bioconjug Chem; 1991; 2(6):422-6. PubMed ID: 1805939
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of RNA miniduplexes via a synthetic linker approach.
Ma MY; Reid LS; Climie SC; Lin WC; Kuperman R; Sumner-Smith M; Barnett RW
Biochemistry; 1993 Feb; 32(7):1751-8. PubMed ID: 7679923
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and physical properties of anti-HIV antisense oligonucleotides bearing terminal lipophilic groups.
MacKellar C; Graham D; Will DW; Burgess S; Brown T
Nucleic Acids Res; 1992 Jul; 20(13):3411-7. PubMed ID: 1630912
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of viral polymerases by chain-terminating substrates: a kinetic analysis.
Wilson JE; Porter DJ; Reardon JE
Methods Enzymol; 1996; 275():398-424. PubMed ID: 9026652
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
